PanACEA Sutezolid Dose-finding and Combination Evaluation

Summary

PanACEA Sutezolid Dose-finding and Combination Evaluation is a clinical trial^[1].

Key Facts

• PanACEA Sutezolid Dose-finding and Combination Evaluation is in the country of South Africa^[2].
• PanACEA Sutezolid Dose-finding and Combination Evaluation is in the country of Tanzania^[3].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's instance of is recorded as clinical trial^[4].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's start time is recorded as +2019-08-31T00:00:00Z^[5].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's end time is recorded as +2020-01-31T00:00:00Z^[6].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's main subject is recorded as tuberculosis^[7].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's number of participants is recorded as {'unit': '1', 'amount': '+75'}^[8].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's title is recorded as A Phase IIB, Open-Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Sutezolid in Combination With Bedaquiline, Delamanid and Moxifloxacin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-sensitive Pulmonary Tuberculosis^[9].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's short name is recorded as SUDOCU^[10].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's ClinicalTrials.gov ID is recorded as NCT03959566^[12].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's research intervention is recorded as bedaquiline^[14].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's clinical trial phase is recorded as phase II clinical trial^[15].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's research site is recorded as Pollita Institute^[16].
• PanACEA Sutezolid Dose-finding and Combination Evaluation's study type is recorded as interventional study^[17].